alivexis-com News Releases

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-27

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-27

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26

Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets

Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-26